Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma (RMC) By Sharon Deveson Kell|2021-10-19T07:58:09+00:0019 Oct 2021|Subtypes of RCC| Renal medullary carcinoma (RMC) is an extremely rare and aggressive [...] Read More Comments Off on Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma (RMC)